Appendix A. Appraisal Committee members and NICE project team
A. Appraisal Committee members
NOTE The Appraisal Committee is a standing advisory committee of the Institute. Its members are appointed for a 3-year term. A list of the Committee members who took part in the discussions for this appraisal appears below. The Appraisal Committee meets twice a month except in December, when there are no meetings. The Committee membership is split into three branches, with the chair, vice-chair and a number of other members between them attending meetings of all branches. Each branch considers its own list of technologies and ongoing topics are not moved between the branches.
Committee members are asked to declare any interests in the technology to be appraised. If it is considered there is a conflict of interest, the member is excluded from participating further in that appraisal.
The minutes of each Appraisal Committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.
Dr Anthony Ades
MRC Senior Scientist, MRC Health Services Research Collaboration, University of Bristol
Dr Tom Aslan
General Practitioner, Stockwell, London
Professor David Barnett (Chair)
Professor of Clinical Pharmacology, University of Leicester
Professor Sheila M Bird
MRC Biostatistics Unit, Cambridge
Professor Rosamund Bryar
Professor of Community and Primary Care Nursing, St Bartholomew's School of Nursing and Midwifery, London
Dr Rodney Burnham
Consultant Physician and Gastroenterologist, Oldchurch Hospital, Romford
Dr Gary Butler
Consultant Paediatrician/Endocrinologist, Leeds General Infirmary
Dr Karl Claxton
Health Economist, University of York
Dr Richard Cookson
Senior Lecturer, Health Economics, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich
Dr Christopher Eccleston
Director, Pain Management Unit, University of Bath
Professor Terry Feest
Clinical Director & Consultant Nephrologist, Richard Bright Renal Unit, & Chair of UK Renal Registry, Bristol
Ms Alison Forbes
Chief Executive, Hoffman de Visme Foundation, London
Professor Gary A Ford
Professor of Pharmacology of Old Age/Consultant Physician, Newcastle upon Tyne Hospitals NHS Trust
Ms Bethan George
Interface Liaison Pharmacist, Tower Hamlets PCT and Royal London Hospital, Whitechapel
Professor John Geddes
Professor of Epidemiological Psychiatry, University of Oxford
Dr Trevor Gibbs
Head, Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline
Mr John Goulston
Director of Finance, Bart's and the London NHS Trust
Mr Adrian Griffin
Health Outcomes Manager, Johnson & Johnson Medical Ltd
Dr Elizabeth Haxby
Lead Clinician in Clinical Risk Management, Royal Brompton Hospital, London
Professor Philip Home
Professor of Diabetes Medicine, University of Newcastle upon Tyne
Dr Catherine Jackson
Clinical Lecturer in Primary Care Medicine, Alyth Health Centre, Angus
Dr Terry John
General Practitioner, The Firs, London
Professor Robert Kerwin
Professor of Psychiatry and Clinical Pharmacology, Institute of Psychiatry, London
Mr Muntzer Mughal
Consultant Surgeon, Lancashire Teaching Hospitals NHS Trust, Chorley
Judith Paget
Chief Executive, Caerphilly Local Health Board, Wales
Dr Katherine Payne
Health Economist, Nowgen: The North West Genetics Knowledge Park, St Mary's Hospital, Manchester
Mr James Partridge
Chief Executive, Changing Faces
Mrs Kathryn Roberts
Nurse Practitioner, Hyde, Cheshire
Professor Philip Routledge
Professor of Clinical Pharmacology, College of Medicine, University of Wales, Cardiff
Ms Anne Smith
Trustee, Long-Term Medical Conditions Alliance
Dr Debbie Stephenson
Head of HTA Strategy, Eli Lilly and Company
Professor Andrew Stevens (Vice-Chair)
Professor of Public Health, University of Birmingham
Dr Cathryn Thomas
General Practitioner, and Senior Lecturer, Department of Primary Care and General Practice, University of Birmingham
Dr Norman Vetter
Reader, Department of Epidemiology, Statistics and Public Health, College of Medicine, University of Wales, Cardiff
Dr Paul Watson
Medical Director, Essex Strategic Health Authority
Dr David Winfield
Consultant Haematologist, Royal Hallamshire Hospital, Sheffield